http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2339368-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c40da4b94bbfac89d9d218a043325a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1d10da2de2ac91ee89e33b3dd7dbe16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-717
filingDate 2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b95ab2595931adad3c1c32a990c629c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4adb8c9db908d12248c6c03fb7b82e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a4cfd24487cf8187ae7f3b139b18bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b1b6bad83272b77b6d5c41a91ba70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a4f0ccfe83eec25e191d3576ca819c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43dca937e4a585f79b0fc5dd3daf47fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1145028f1e0d7fa43feeef3b7d479b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3859b309c2cc3772f697ba0d6da46c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394c415b0e089bac2383d2daed10af86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f316c309edfd8c4691f5cc1897d0fc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cca473695b053d983ed26d999374331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2812f4fa5af252ecba4bd9918f76f0d4
publicationDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2339368-C1
titleOfInvention Method for treatment of extensive peritonitis
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, particularly to abdominal surgery, and applied to treatment for extensive peritonitis. To do it during operative intervention the peritonitis source is eliminated, and abdominal cavity sanation is performed. Then 3% methylcellulose gel, preliminary saturated with 1200 mg/l sodium hypochlorite solution in proportion 3:1, is introduced. n EFFECT: preventing of parietal and visceral peritoneum mesothelium injury by microbial exo- and endotoxins, anti-microbial effect prolongation of sodium hypochlorite, and preventing inactivation of sodium hypochlorite by peritoneal toxic effluent. n 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2468760-C1
priorityDate 2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452802464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14055602

Total number of triples: 36.